Susquehanna International Group
RNAM

Susquehanna International Group’s Avidity Biosciences RNAM Stock Holding History

Susquehanna International Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,427,100
Closed -$103M – 13968
2025
Q4 		$103M Buy
1,427,100
+1,231,100
+628% +$79.5M 0.01% 867
2025
Q3 		$8.54M Buy
196,000
+127,500
+186% +$5.15M ﹤0.01% 3250
2025
Q2 		$1.95M Sell
68,500
-42,500
-38% -$1.27M ﹤0.01% 5842
2025
Q1 		$3.28M Buy
111,000
+98,900
+817% +$3.08M ﹤0.01% 4483
2024
Q4 		$352K Sell
12,100
-24,200
-67% -$1.01M ﹤0.01% 9472
2024
Q3 		$1.67M Sell
36,300
-100,100
-73% -$4.34M ﹤0.01% 5669
2024
Q2 		$5.57M Buy
136,400
+85,500
+168% +$2.45M ﹤0.01% 3276
2024
Q1 		$1.3M Buy
50,900
+23,600
+86% +$370K ﹤0.01% 6302
2023
Q4 		$247K Buy
+27,300
New +$182K ﹤0.01% 10239
2023
Q3 		– Sell
-21,700
Closed -$241K – 12822
2023
Q2 		$241K Buy
+21,700
New +$272K ﹤0.01% 9892
2023
Q1 		– Sell
-67,800
Closed -$1.5M – 13348
2022
Q4 		$1.5M Buy
+67,800
New +$1.01M ﹤0.01% 5277

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Susquehanna International Group's RNAM Position: Q1 2026 in Review

Susquehanna International Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 268,393 shares — an estimated $19.4M sold.

Susquehanna International Group first reported a position in RNAM in Q3 2020 and held it in 21 quarters. The position peaked at $19.4M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Susquehanna International Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 268,393 Avidity Biosciences shares in Q1 2026, an estimated $19.4M.
  • Susquehanna International Group first reported a position in Avidity Biosciences in Q3 2020 and held it in 21 quarters.
  • Susquehanna International Group's Avidity Biosciences position peaked at $19.4M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.